Top-line data from a key study show that BoneSupport Holding AB's synthetic bone graft Cerament is safe and effective for the treatment of tibia plateau fracture defects as autografts.
The Swedish orthobiologics company says the data suggest Cerament may "catalyse a change in the standard of care for this kind of injury" because it does not require a second surgery to harvest autologous tissue. Cerament is an injectable bio ceramic bone scaffold that provides targeted drug-elution directly into the bone void and remodels the host bone in six to 12 months
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?